Gapping up
In reaction to earnings/guidance:
- TTI +3.8% (guidance)
Other news:
- RIVN +5.9% (Amazon (AMZN) rolls out first electric delivery vans from Rivian in Europe)
- DWAC +5.8% (disclosed agreement in principle with the staff of the SEC's Division of Enforcement)
- NIU +4.8% (reports Q2 sales volumes)
- CCCC +3.9% (receives FDA Clearance of Investigational New Drug Application for CFT8919)
- RIG +3.6% (announced that six one-well options have been exercised for the Transocean Encourage in Norway)
- AXTI +3.1% (Addresses China's Announcement of New Export Control Regulations)
- EVO +3.1% (awarded second contract from U.S. Department of Defense under accelerated antibodies program)
- DHT +2.6% (provides share buyback update)
- AEL +2.4% (Brookfield Reinsurance to acquire AEL in $4.3 billion transaction)
- INCY +1.5% (MHRA grants marketing authorization for Opzelura cream for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents)
- USO +1% (rising with crude futures)